Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 20804967.
- Also identified by DOI 10.1016/j.stem.2010.08.002 and PMC identifier 4959883.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Polycomb Group (PcG) proteins are transcriptional repressors that epigenetically modify chromatin and participate in the establishment and maintenance of cell fates. These proteins play important roles in both stem cell self-renewal and in cancer development. Our understanding of their mechanism of action has greatly advanced over the past 10 years, but many unanswered questions remain. In this review, we present the currently available experimental data that connect PcG protein function with some of the key processes which govern somatic stem cell activity. We also highlight recent studies suggesting that a delicate balance in PcG gene dosage is crucial for proper stem cell homeostasis and prevention of cancer stem cell development.
Medical subject headings
- Neoplastic Stem Cells
- Repressor Proteins
- Stem Cells